1. Home
  2. GALT vs FRSX Comparison

GALT vs FRSX Comparison

Compare GALT & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GALT
  • FRSX
  • Stock Information
  • Founded
  • GALT 2000
  • FRSX N/A
  • Country
  • GALT United States
  • FRSX Israel
  • Employees
  • GALT N/A
  • FRSX N/A
  • Industry
  • GALT Biotechnology: Pharmaceutical Preparations
  • FRSX Computer Software: Prepackaged Software
  • Sector
  • GALT Health Care
  • FRSX Technology
  • Exchange
  • GALT Nasdaq
  • FRSX Nasdaq
  • Market Cap
  • GALT 54.6M
  • FRSX 31.1M
  • IPO Year
  • GALT N/A
  • FRSX 2017
  • Fundamental
  • Price
  • GALT $1.18
  • FRSX $1.72
  • Analyst Decision
  • GALT Hold
  • FRSX
  • Analyst Count
  • GALT 1
  • FRSX 0
  • Target Price
  • GALT N/A
  • FRSX N/A
  • AVG Volume (30 Days)
  • GALT 1.6M
  • FRSX 1.8M
  • Earning Date
  • GALT 11-13-2024
  • FRSX 11-29-2024
  • Dividend Yield
  • GALT N/A
  • FRSX N/A
  • EPS Growth
  • GALT N/A
  • FRSX N/A
  • EPS
  • GALT N/A
  • FRSX N/A
  • Revenue
  • GALT N/A
  • FRSX $473,000.00
  • Revenue This Year
  • GALT N/A
  • FRSX N/A
  • Revenue Next Year
  • GALT N/A
  • FRSX N/A
  • P/E Ratio
  • GALT N/A
  • FRSX N/A
  • Revenue Growth
  • GALT N/A
  • FRSX 3.28
  • 52 Week Low
  • GALT $0.73
  • FRSX $0.57
  • 52 Week High
  • GALT $4.27
  • FRSX $2.63
  • Technical
  • Relative Strength Index (RSI)
  • GALT 29.90
  • FRSX 64.88
  • Support Level
  • GALT $0.76
  • FRSX $1.63
  • Resistance Level
  • GALT $1.47
  • FRSX $2.63
  • Average True Range (ATR)
  • GALT 0.25
  • FRSX 0.32
  • MACD
  • GALT -0.09
  • FRSX 0.12
  • Stochastic Oscillator
  • GALT 22.70
  • FRSX 52.60

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its advanced systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.

Share on Social Networks: